CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.
Sunakawa Y, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Ichikawa W.
Sunakawa Y, et al. Among authors: kochi m.
Target Oncol. 2017 Dec;12(6):787-794. doi: 10.1007/s11523-017-0527-0.
Target Oncol. 2017.
PMID: 29064002